Skip to main content

A.D.A.M

ApplicationFarmington, CT, USAFounded 2018· One of 313 Application companies tracked by AMPulse

Develops on-demand personalized implant manufacturing infrastructure using proprietary 3D printing technology and material composites for medical applications.

CEO / Founder
Denys Gurak
Team Size
11-50
Stage
Defunct
Total Funding
$2.4M
Latest Round
Series A
Key Investors
Techstars, WeFund, Hub71, Million Dollar Round Table (MDRT), and various angel investors.

Technology & Products

Key Products

Proprietary 3D printing technology; Material composites for personalized implants

Technological Advantage

The infrastructure supports both remote and on-site manufacturing, allowing for decentralized production of patient-specific medical devices.

Differentiation

Value Proposition

Provides on-demand personalized medical implants through a remote or on-site infrastructure, utilizing proprietary material composites to enable patient-specific surgical solutions.

How They Differentiate

Utilizes a decentralized 'factory-in-a-box' model for on-site hospital manufacturing, significantly reducing lead times for personalized implants. Their proprietary bio-resorbable material is naturally replaced by natural bone over time, unlike permanent metal or PEEK alternatives.

Market & Competition

Target Customers

Hospitals, orthopedic surgical centers, and medical device distributors requiring patient-specific bone implants and point-of-care manufacturing solutions.

Industry Verticals

Medical

Competitors

Particle 3D, Cerhum, Oxford Performance Materials

Growth & Milestones

Growth Metrics

Raised $2.4M in seed funding; completed Techstars Hub71 and Starburst accelerators; currently in the FDA pre-submission phase for its 3D-printed bone implants.

Major Milestones

Founded in 2018; Launched crowdfunding campaign on StartEngine; Signed collaboration agreement with West Virginia Entities (February 20, 2024)

Notable Customers

Masovian Regional Hospital (Siedlce, Poland); Ministry of Health of Ukraine; Icahn School of Medicine at Mount Sinai; West Virginia Department of Economic Development; Marshall Advanced Manufacturing Center; CMI2 (Civil-Military Innovation Institute); Applied Medical; Stanley Black & Decker; University of Connecticut (UConn); Yale University; Lund University; Eindhoven University of Technology (TU/e); ARMI (Advanced Regenerative Manufacturing Institute)